Telehealth Behavioral Migraine Management
Launched by ALBERT EINSTEIN COLLEGE OF MEDICINE · Jun 8, 2019
Trial Information
Current as of August 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Physician diagnosis of migraine
- • Current self-reported symptoms meeting the International Classification for Headache Disorders -- 3 criteria for migraine
- • Self-reported between 4 and 20 headache days/month
- • Aged 18-65
- • Can read English
- • Capacity to consent
- Exclusion Criteria:
- • Psychiatric illness that would interfere with study participation
- • Meeting criteria for probable medication overuse headache
About Albert Einstein College Of Medicine
Albert Einstein College of Medicine is a leading academic institution dedicated to advancing biomedical research and medical education. Situated in the Bronx, New York, it is renowned for its commitment to innovative research and training the next generation of physicians and scientists. The college actively engages in a wide range of clinical trials, focusing on translating scientific discoveries into effective therapies and improving patient care. With a collaborative approach that involves multidisciplinary teams, Albert Einstein College of Medicine aims to address significant health challenges and contribute to the global medical community through rigorous research and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bronx, New York, United States
Patients applied
Trial Officials
Elizabeth K Seng, Ph.D.
Principal Investigator
Yeshiva University/Albert Einstein College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials